e-learning
resources
London 2016
Sunday, 04.09.2016
Novel insights into alveolar and bronchial epithelial cell injury and repair
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal stem cells?
Raquel Guillamat-Prats (Barcelona, Spain), Raquel Guillamat-Prats, Marta Camprubí-Rimblas, Ferranda Puig, Raquel Herrero, Anna Serrano-Mollar, Jessica Tijero, Maria Nieves Gómez, Lluís Blanch, Antonio Artigas
Source:
International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Session:
Novel insights into alveolar and bronchial epithelial cell injury and repair
Session type:
Thematic Poster
Number:
945
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Raquel Guillamat-Prats (Barcelona, Spain), Raquel Guillamat-Prats, Marta Camprubí-Rimblas, Ferranda Puig, Raquel Herrero, Anna Serrano-Mollar, Jessica Tijero, Maria Nieves Gómez, Lluís Blanch, Antonio Artigas. Cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal stem cells?. Eur Respir J 2016; 48: Suppl. 60, 945
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
LATE-BREAKING ABSTRACT: Human mesenchymal stem cell exosomes attenuates sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-?B pathway
Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage
Year: 2015
Heparin effect in alveolar cells and macrophages in an acute lung injury model
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Heparin effect in pulmonary cell populations in an in-vitro model of acute lung injury
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
Methotrexate reduces acute lung injury in a murine model of sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
LATE-BREAKING ABSTRACT: Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016
LATE-BREAKING ABSTRACT: Trasplantation of alveolar type II cells in experimental Acute Lung Injury
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Essential oils reduced lung inflammation in a model of acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Expression of water and ion channels proteins in acute respiratory distress syndrome from different etiologies
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Effects of ceramide pathway inhibition on the inflammatory response in lipopolysacharide-triggered lung injury
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Effect of alveolar type II cells in acute lung injury model
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Outcome of acute drug-induced pneumonias in ICU
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Characterization of ceramide generation kinetics in a lung injury model induced by lipopolysaccharide
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Human mesenchymal stem cells (MSC) modulate alveolar macrophage polarization
in vivo
and
in vitro.
Source: International Congress 2014 – Acute lung injury: hitting the barriers
Year: 2014
Mesenchymal stem cell-conditioned medium induces neutrophils apoptosis via inhibition of NF-kB pathway and increases endogenous pulmonary stem cells in endotoxin-induced acute lung injury
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
Microvesicles derived from alveolar macrophages mediate epithelial activation via a TNF dependant mechanism
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Long-term effects of nebulized LPS in a mouse model of acute lung injury (ALI)
Source: International Congress 2014 – ILDs 6
Year: 2014
The role of SIRT1 in LPS-induced lung endothelial barrier dysfunction and lung injury in vivo
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Markers of poor outcome in patients with acute hypoxemic respiratory failure
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept